Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
India Business grew by 11.9% YoY to Rs. 1196.2 crore
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa Capsules, 110 mg of Boehringer Ingelheim Pharmaceuticals
This project is supported by the Irish Government through IDA Ireland
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Expect the international business including CDMO business to pick-up in the second half of the financial year
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Subscribe To Our Newsletter & Stay Updated